- Home
- CAMT vs ICLR Comparison
CAMT vs ICLR Comparison
Compare CAMT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAMT | ICLR |
|---|---|---|
| Founded | 1987 | 1990 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CAMT | ICLR |
|---|---|---|
| Price | $157.26 | $88.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $128.45 | ★ $202.31 |
| AVG Volume (30 Days) | 561.3K | ★ 3.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.66 | N/A |
| Revenue Next Year | $6.12 | $0.22 |
| P/E Ratio | $155.10 | ★ $11.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.41 | $66.57 |
| 52 Week High | $164.21 | $211.00 |
Technical Indicators
Market Signals| Indicator | CAMT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 60.35 | 21.76 |
| Support Level | $154.26 | $66.57 |
| Resistance Level | $163.19 | $96.55 |
| Average True Range (ATR) | 8.70 | 10.92 |
| MACD | 0.37 | -9.39 |
| Stochastic Oscillator | 76.41 | 18.18 |
Price Performance
Historical ComparisonAbout CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.